患者对长期艾滋病毒治疗的偏好:偏好异质性评估
Enrique M Saldarriaga1, Brett Hauber2,3, Douglas Barthold2
1The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, University of Washington, 1959 Pacific St NE, Seattle, WA, 98107, USA. emsb@uw.edu.
BMC infectious diseases
|February 19, 2025
概括
长效抗逆转录病毒疗法 (LA-ART) 显示出改善艾滋病毒治疗坚持治疗的前景. 患者的偏好各不相同,有些人喜欢植入物或注射,而另一些人更喜欢每天服用口服药片或在家服用LA口服药片.
科学领域:
- 艾滋病毒/艾滋病 治疗
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- 长效抗逆转录病毒疗法 (LA-ART) 是每天服用口服药物的替代方案,有可能提高艾滋病毒治疗的坚持.
- 了解患者对LA-ART的偏好对于其成功实施至关重要.
研究的目的:
- 调查艾滋病毒感染者 (PWH) 中对LA-ART的偏好异质性.
- 确定个体特征如何与对LA-ART模式的不同偏好有关.
主要方法:
- 一项对699名PWH的调查包括17个选择任务,比较假设的LA-ART选择 (口服,皮下注射,肌内注射,植入物) 与每日口服治疗.
- 隐性类型建模用于分析基于模式,频率,位置,注射疼痛和其他因素的偏好.
- 研究了确定偏好类和个体特征之间的关联.
主要成果:
- 出现了三个不同的偏好类别:LA-植入物 (29%),LA-口服或注射 (35%) 和每日或LA-口服 (36%).
- 两个类偏爱LA-ART (植入物或口服/注射),其特点是年龄较小,高等教育,坚持较低,注射厌恶程度较低.
- LA-Implant组的病毒抑制率较低,更容易进入诊所;LA-Oral-or-Injection组的精神障碍率较高.
结论:
- 在PWH中对于LA-ART存在显著的偏好异质性.
- 根据个人偏好调整LA-ART干预措施,考虑年龄,坚持和特定健康状况等因素,可以改善治疗结果.
相关概念视频
Retrovirus Life Cycles
45.6K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.6K
Analysis of Population Pharmacokinetic Data
216
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
216


